Please login to the form below

Not currently logged in
Email:
Password:

ConfometRx

This page shows the latest ConfometRx news and features for those working in and with pharma, biotech and healthcare.

UCB signs research deal for novel neuroscience drugs

UCB signs research deal for novel neuroscience drugs

The Belgium-based biopharma firm is collaborating with ConfometRx, a California-based company that was co-founded by Stanford University professor and Nobel Prize winner Brian Kobilka. ... The two-year multi-target agreement will see UCB and ConfometRx

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics